Neoplasia/BPH

	Artificial Intelligence in Digital Pathology for Prostate Cancer Detection: FDA Clearance and Real-World Implementation. J Clin Pathol Rainer Q, Sun Y, Vyas M, Kopach P, Gondim D, Muthukumarana V, Thaker H, Deshpande V. PMID: 42468971 [PubMed - as supplied by publisher]
	Prognostic role of the Glasgow prognostic score and modified Glasgow prognostic score in patients with renal cell carcinoma undergoing immunotherapy: a meta-analysis. Clinics (Sao Paulo) Zhang X, Li X, Xie Y, Shi N. PMID: 42468376 [PubMed - as supplied by publisher]
	Patient-Reported Outcome Design and Analysis in Randomized Controlled Trials of Renal Cell Carcinoma: A Systematic Review. Clin Genitourin Cancer Chen D, Chen S, Sun D, Chow E, Lee SF, Wong HCY, Raman S. PMID: 42468185 [PubMed - as supplied by publisher]
	Emerging antibody-drug conjugates in metastatic castration-resistant prostate cancer. Urol Oncol Nguyen CB, Reichert ZR. PMID: 42469055 [PubMed - as supplied by publisher]
	Reply to Antonio Cigliola, Andrea Necchi, and Umberto Capitanio's Letter to the Editor Re: Metastasis-directed Therapy with or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024. Eur Urol Sherry AD, To V, Msaouel P, Neeson P, Tang C, Siva S. PMID: 42469054 [PubMed - as supplied by publisher]
	Radiation-induced erectile dysfunction in prostate cancer: A systematic review of pathophysiology, clinical radiobiology, and predictive modeling. Phys Med Saraei P, Bagheri A, Danyaei A, Jafari M, Salek R, Hosseini S, Obeidavi I, Chegeni N. PMID: 42468493 [PubMed - as supplied by publisher]
	Automated volumetric iRECIST-inspired CT assessment of treatment response to dual immune checkpoint inhibition in metastatic renal cell carcinoma: A feasibility study. Eur J Radiol Kraaijveld RCJ, Ma B, Suelmann BBM, Wessels FJ, Ragusi MAA, de Keizer B, Gilhuijs KGA. PMID: 42468161 [PubMed - as supplied by publisher]
	Occupational exposure to metals and prostate cancer: CAPLIFE study. Cancer Epidemiol Olmedo-Requena R, Villanueva-Piqueras PJ, Lozano-Lorca M, Castillo-Hermoso MÁ, Jiménez-Moleón JJ, Salcedo-Bellido I. PMID: 42468082 [PubMed - as supplied by publisher]
	A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) for the Treatment of Non-Muscle Invasive BCG Unresponsive Urothelial Carcinoma of the Bladder. J Urol DeCastro GJ, Joffe BI, Stein MN, Abate-Shen C, Miles CH, Gray JM, Anderson CB, Lenis AT, McKiernan JM. PMID: 42467648 [PubMed - as supplied by publisher]
	Real-World Use of ProlarisÂ® to Guide Treatment Decisions in Localized Prostate Cancer Eligible for Active Surveillance. Urol Int Melchior F, Koett M, Aigner G, Schroffenegger J, Weiss B, Ormanns S, Heidegger I. PMID: 42467602 [PubMed - as supplied by publisher]
	Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications. World J Urol McMaster T, McVeigh N, Chen DC, Al-Khanaty A, Sandhu K, Carll J, Woon DT, Murphy DG, Lawrentschuck N, Au L, Ali M, Siva S, Perera M. PMID: 42467100 [PubMed - indexed for MEDLINE]
	A Nationwide Descriptive Analysis of Real-World Outcomes After Radical Prostatectomy in Japan Using the National Clinical Database. Int J Urol Sakamoto S, Yamamoto K, Yamamoto H, Hatakeyama S, Mizuno R, Yasui T, Kamoto T, Kikuchi E, Ito A, Kume H. PMID: 42466819 [PubMed - indexed for MEDLINE]
	Machine Learning Classification of Prostate Cancer Genomic Sequences Using K-Mer and Sequence-Derived Features. Comput Mol Biosci Rawat K, Banerjee HN, Noble J, Deloatch SN, Banerjee S, Shetty S, Banerjee S. PMID: 42466157 [PubMed]
	Correction to an immunometabolism-related signature for renal clear cell carcinoma diagnosis and therapeutic target. J Cell Commun Signal PMID: 42465982 [PubMed]
	Tumor heterogeneity on contrast-enhanced computed tomography outperforms attenuation ratio in differentiating renal cell carcinoma subtypes: a pathologic correlation study. Pan Afr Med J Araminta ADE, Atmaja MHS, Ferriastuti W. PMID: 42465830 [PubMed - indexed for MEDLINE]
	The diagnostic value of biparametric magnetic resonance imaging vesical imaging-reporting and data system combined with tumor contact length for assessing muscle invasion in bladder cancer lesions scored vesical imaging-reporting and data system 3: A single-center retrospective analysis. Indian J Urol Bao W, Liu Y, Yang J, Ma X. PMID: 42465796 [PubMed]
	The immunotherapy paradox in high-risk non-muscle-invasive bladder cancer: A tale of three trials. Indian J Urol Agrawal S, Pal AK, Sharma S, Tanwar R, Sharma G. PMID: 42465794 [PubMed]
	The Evidence-Practice Gap in Testosterone Therapy for Prostate Cancer: A Narrative Review. Cureus Aly M, Joseph A, Amer T. PMID: 42465160 [PubMed]
	Prostate Cancer Screening: Current Controversies and Future Directions. Cureus Buali HF, Al Shaibani A, Farouqi US, Abushloa T, Bastawisy A, Aljeeran N, Albenjasim K, Rafie M. PMID: 42465149 [PubMed]
	Post-Marketing Surveillance of the Safety and Effectiveness of Cabozantinib in Japanese Patients With Advanced Renal Cell Carcinoma. Int J Urol Kanayama HO, Kuroda S, Osaka T, Eto M. PMID: 42464667 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 189857

Page 1 of 9493



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy